Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) - FASTR Trial

NCT05174312 is registered in ClinicalTrials.gov with Reprieve Cardiovascular, Inc as lead sponsor.

NCT NCT05174312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05174312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) - FASTR Trial
Lead sponsor
Reprieve Cardiovascular, Inc
Phase
Not applicable
Overall status
Completed
Start date
July 11, 2022
Completion date
January 10, 2025
Enrollment
100 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure